Who owns Pds Biotechnology Ord?
- Ticker: PDSB
- CUSIP Number: 70465t107
Tip: Access positions for across all investors
Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pds Biotechnology Ord stock
Who bought or sold Pds Biotechnology Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.0M | $1.5M | 3% | Dec 2025 |
|
| BlackRock | 522k | $402k | 1% | Dec 2025 |
|
| Geode Capital Management | 520k | $401k | 8% | Dec 2025 |
|
| Citadel Advisors | 415k | $419k | 34% | Sep 2025 |
|
| UBS Group | 252k | $194k | 26% | Dec 2025 |
|
| William Blair $ Company | 250k | $253k | 0% | Sep 2025 |
|
| Commonwealth Equity Services | 197k | $152k | 117% | Dec 2025 |
|
| Squarepoint Ops | 193k | $148k | -34% | Dec 2025 |
|
| Integrys Wealth Advisors | 181k | $139k | -48% | Dec 2025 |
|
| Renaissance Technologies | 177k | $136k | -36% | Dec 2025 |
|
| Northern Trust | 144k | $111k | 27% | Dec 2025 |
|
| State Street Corporation | 133k | $103k | 0% | Dec 2025 |
|
| Amussen Hunsaker & Associates | 75k | $58k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 69k | $53k | 137% | Dec 2025 |
|
| Tempus Wealth Planning | 62k | $48k | 29% | Dec 2025 |
|
| Watts Gwilliam & Co | 55k | $56k | 0% | Sep 2025 |
|
| Susquehanna International | 39k | $30k | -59% | Dec 2025 |
|
| XTX Topco | 34k | $26k | 74% | Dec 2025 |
|
| Virtu Financial | 32k | $25k | 100% | Dec 2025 |
|
| ACT Capital Management | 30k | $23k | 100% | Dec 2025 |
|
| Rockefeller Capital Management | 26k | $20k | -26% | Dec 2025 |
|
| Simplex Trading | 19k | $15k | 54% | Dec 2025 |
|
| Intl Fcstone | 16k | $12k | 100% | Dec 2025 |
|
| First Manhattan | 15k | $12k | 0% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 15k | $11k | -21% | Dec 2025 |
|
| Ground Swell Capital | 15k | $11k | 100% | Dec 2025 |
|
| Raymond James Financial | 14k | $14k | -1% | Sep 2025 |
|
| Wealth Group | 13k | $10k | 0% | Dec 2025 |
|
| Davenport & Co | 10k | $7.7k | 100% | Dec 2025 |
|
| Grandfield & Dodd | 10k | $7.7k | 0% | Dec 2025 |
|
| Kathleen S. Wright Associates | 7.0k | $7.1k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 5.3k | $4.1k | 0% | Dec 2025 |
|
| Group One Trading | 3.9k | $3.0k | 100% | Dec 2025 |
|
| Creative Financial Designs | 3.0k | $2.3k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.2k | $1.7k | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 2.0k | $2.0k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 1.9k | $2.1k | -74% | Sep 2025 |
|
| FMR | 1.0k | $1.0k | -2% | Sep 2025 |
|
| Truvestments Capital | 655.00 | $504.022500 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 648.00 | $499.024800 | -43% | Dec 2025 |
|
| Jpmorgan Chase & Co | 619.00 | $625.004300 | 100% | Sep 2025 |
|
| SBI Securities | 110.00 | $111.001000 | -47% | Sep 2025 |
|
| Advisor Group Holdings | 17.00 | $12.999900 | 0% | Dec 2025 |
|
Who sold out of Pds Biotechnology Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caption Management | Sep 2025 | 219k | $221k |
| Millennium Management | Jun 2025 | 81k | $108k |
| Acadian Asset Management | Sep 2025 | 62k | $61k |
| Jane Street | Sep 2025 | 37k | $37k |
| Dimensional Fund Advisors | Sep 2025 | 18k | $19k |
| Two Sigma Securities | Sep 2025 | 14k | $14k |
| Marex Group | Jun 2025 | 14k | $19k |
| Mercer Global Advisors | Sep 2025 | 13k | $13k |
| Stratos Wealth Partners | Sep 2025 | 11k | $11k |
| Cubist Systematic Strategies | Jun 2025 | 11k | $14k |
| Baader Bank | Sep 2025 | 11k | $6.6k |
| J.W. Burns & Company | Sep 2025 | 10k | $10k |
| Rialto Wealth Management | Sep 2025 | 400.00 | $404.000000 |
| Point72 | Jun 2025 | 50.00 | $66.000000 |